Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator-controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (VOYAGE 1)
Clinical Trial ( IRB ) #: 15-118-1
Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator-controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (VOYAGE 1)
Principal Investigator: Dr. Bruce Strober
Description: Study description not available
Classification:
  Other
  Skin
Eligibility Criteria: Check with study contact
How to Contact: Cheryl Martin. Telephone: (860) 679-3475. Email: Cmartin@uchc.edu
Enrollment Status/Comments: No longer enrolling